40 original long-form articles, each written and edited in-house. More are published every week.
DeepMind's AlphaFold has effectively solved the static protein folding problem. However, understanding how proteins move and interact in a biological system remains a distinct and complex computational challenge for drug discovery.
Aug 8, 2026 · 13 min · 2,982 words
An approved therapy for sickle cell disease proved genome editing can treat inherited illness. Delivery — not editing — is what decides which diseases come next.
Aug 4, 2026 · 7 min · 1,608 words
Messenger RNA technology is evolving into a versatile therapeutic platform. By modifying lipid nanoparticle chemistry, researchers are attempting to direct genetic instructions to specific organs to treat metabolic disorders and cancers.
Jul 30, 2026 · 13 min · 2,870 words
Current gene delivery systems rely on viral vectors that naturally accumulate in the liver. Engineering these particles to reach other tissues without triggering immune responses remains the primary technical hurdle in genomic medicine.
Jul 18, 2026 · 12 min · 2,798 words
Engineering microorganisms to produce high-value chemicals requires precise control over metabolic flux. However, biological instability and thermodynamic shifts during scale-up frequently prevent laboratory successes from reaching industrial viability.
Jun 30, 2026 · 14 min · 3,048 words
Biological aging is no longer viewed as an inevitable decline but as a series of distinct cellular failures. Researchers are now attempting to categorise these mechanisms to develop targeted pharmacological interventions.
Jun 6, 2026 · 13 min · 3,019 words
High-throughput sequencing has linked gut microbes to various human illnesses, yet defining causal mechanisms requires moving beyond statistical association toward controlled germ-free animal models and specific metabolic pathway analysis.
May 19, 2026 · 13 min · 2,972 words